Literature DB >> 200349

Tumor-associated immunoglobulins in pulmonary carcinoma.

B Gerstl, L F Eng, J W Bigbee.   

Abstract

In view of the uncertainty of location and significance of immunoglobulin in tumors found by elution or rosette formation (as reported in the literature), the presence of IgG, IgM, and IgA in human carcinoma of the lung was studied by means of the peroxidase-antiperoxidase method. Surgically obtained specimens from patients with known survival times were used in this study. Membranous as well as cytoplasmic location of IgG was demonstrated more frequently than was that of IgA or IgM. The number of tumor cells carrying immunoglobulin varied greatly, even within a given case. Albumin could be demonstrated in tumor cells in 10 of 20 specimens, but there was poor correlation with immunoglobuin. In some instances, only the necrotic part of the tumor or the stroma was immunoreactive. The results are discussed and suggest that Fc receptors are not involved in the binding of immunoglobin by pulmonary carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200349

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

Review 1.  B cells, plasma cells and antibody repertoires in the tumour microenvironment.

Authors:  George V Sharonov; Ekaterina O Serebrovskaya; Diana V Yuzhakova; Olga V Britanova; Dmitriy M Chudakov
Journal:  Nat Rev Immunol       Date:  2020-01-27       Impact factor: 53.106

2.  Immunohistochemical demonstration of IgG in meningioma.

Authors:  K Tabuchi; Y Kawakami; A Nishimoto
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

3.  Bronchial carcinoma presenting as autoimmune haemolytic anaemia.

Authors:  R Cooper; J A Tappin; S Deveshevar
Journal:  Postgrad Med J       Date:  1981-08       Impact factor: 2.401

Review 4.  The neglected brothers come of age: B cells and cancer.

Authors:  Shabnam Shalapour; Michael Karin
Journal:  Semin Immunol       Date:  2021-06-29       Impact factor: 10.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.